From the first article: "We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity
in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans."
So one of the drugs has the potential to be effective against SARS-CoV-2 virus. The other has the potential to eliminate future moronic slappies that would feel superior in the Ivermectin debate without actually getting any facts.
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited…
www.sciencedirect.com
Objective: This study was designed to determine the efficacy of ivermectin, an FDA-approved drug, in producing clinical benefits and decreasing the viral load of SARS-CoV-2 among asymptomatic subjects that tested positive for this virus in Lebanon. Methods: ...
www.ncbi.nlm.nih.gov
Official answer: Ivermectin is not FDA approved to treat COVID-19 patients. Ivermectin should only be used in patients for COVID-19...
www.drugs.com